Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1993-5-25
|
pubmed:abstractText |
To clarify the interaction between endothelin-1 (ET-1) and atrial natriuretic peptide (ANP), the effects of ET-1 on ANP secretion were investigated in isolated perfused rat hearts and in conscious unrestrained rats. Perfusion with 10(-9) M ET-1 stimulated ANP secretion from the isolated perfused rat heart. However, 10(-10) M ET-1 significantly decreased ANP secretion for the initial 15 min of the perfusion period. The perfusion with 10(-11) M ET-1, which is near the plasma level of ET-1 (2 x 10(-12) M), inhibited ANP secretion throughout the perfusion period. The perfusion of 10(-12) M ET-1 slightly decreased ANP secretion. After the ET-1 perfusion period, ANP secretion increased in proportion to ET-1 dose. The inhibitory action of ET-1 on ANP secretion was almost abolished by simultaneous perfusion of indomethacin, a cyclooxygenase inhibitor, but not by methylene blue, an inhibitor of soluble guanylate cyclase. In conscious unrestrained rats the iv infusion of 1 pmol/kg.min ET-1, which doubled the plasma ET-1 level, slightly but significantly decreased the plasma ANP level 5 and 10 min after the initiation of the infusion. The infusion of 10 and 30 pmol/kg.min ET-1 increased the plasma ANP level. These results demonstrate that low doses of ET-1 exert an inhibitory and short-acting action on ANP secretion from the heart, although high doses of ET-1 exert stimulating and long-lasting action, and suggest that prostanoids are involved in this inhibitory action.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0013-7227
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
132
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1905-12
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8477643-Animals,
pubmed-meshheading:8477643-Atrial Natriuretic Factor,
pubmed-meshheading:8477643-Blood Pressure,
pubmed-meshheading:8477643-Dose-Response Relationship, Drug,
pubmed-meshheading:8477643-Endothelins,
pubmed-meshheading:8477643-Heart,
pubmed-meshheading:8477643-Heart Rate,
pubmed-meshheading:8477643-Indomethacin,
pubmed-meshheading:8477643-Kinetics,
pubmed-meshheading:8477643-Male,
pubmed-meshheading:8477643-Methylene Blue,
pubmed-meshheading:8477643-Perfusion,
pubmed-meshheading:8477643-Pressure,
pubmed-meshheading:8477643-Rats,
pubmed-meshheading:8477643-Rats, Inbred WKY
|
pubmed:year |
1993
|
pubmed:articleTitle |
Low doses of endothelin-1 inhibit atrial natriuretic peptide secretion.
|
pubmed:affiliation |
Department of Medicine, Kyoto University School of Medicine, Japan.
|
pubmed:publicationType |
Journal Article,
In Vitro
|